Literature DB >> 3107241

Interleukin-1: amino acid sequences, multiple biological activities and comparison with tumor necrosis factor (cachectin).

C A Dinarello.   

Abstract

Interleukin-1 (IL-1) now refers to a family of polypeptides which are produced by the host in response to injury, infection, and various immunological reactions. To date, two forms have been cloned but there are likely others. Recombinant IL-1s confirm the multiple and diverse biological properties that had been described previously using natural IL-1s. In this review, the cloning approaches for are discussed; in addition, the molecular control of IL-1 synthesis and processing are considered. The various biological activities of recombinant IL-1s are presented and are discussed regarding their clinical relevance. The multiple biological activities of recombinant tumor necrosis factor (cachectin) are compared to those of recombinant IL-1s.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3107241

Source DB:  PubMed          Journal:  Year Immunol        ISSN: 0256-2308


  24 in total

Review 1.  The proteasome: a central regulator of inflammation and macrophage function.

Authors:  Nilofer Qureshi; Stefanie N Vogel; Charles Van Way; Christopher J Papasian; Asaf A Qureshi; David C Morrison
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

2.  Interleukin 1 beta in synovial fluid is related to local disease activity in rheumatoid arthritis.

Authors:  M Rooney; J A Symons; G W Duff
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

3.  Interleukin 1 inhibits contraction of vascular smooth muscle.

Authors:  D Beasley; R A Cohen; N G Levinsky
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

Review 4.  The interleukins in acquired disease.

Authors:  M Malkovský; P M Sondel; W Strober; A G Dalgleish
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

5.  Absence of correlations between indices of systemic inflammation and synovial fluid interleukin 1 (alpha and beta) in rheumatic diseases.

Authors:  F S di Giovine; S Poole; R D Situnayake; M Wadhwa; G W Duff
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

6.  Expression of membrane interleukin 1 by fibroblasts transfected with murine pro-interleukin 1 alpha cDNA.

Authors:  R C Fuhlbrigge; S M Fine; E R Unanue; D D Chaplin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

7.  Tumour necrosis factor in synovial exudates.

Authors:  F S Di Giovine; G Nuki; G W Duff
Journal:  Ann Rheum Dis       Date:  1988-09       Impact factor: 19.103

8.  Cytokines in synovial fluid. I. The presence of biologically active and immunoreactive IL-1.

Authors:  S J Hopkins; M Humphreys; M I Jayson
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

9.  Effect of tenidap on cartilage integrity in vitro.

Authors:  J T Dingle; M R Leeming; J J Martindale
Journal:  Ann Rheum Dis       Date:  1993-04       Impact factor: 19.103

10.  Interleukin 1 stimulates phosphatidylinositol kinase activity in human fibroblasts.

Authors:  L R Ballou; S C Barker; A E Postlethwaite; A H Kang
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.